.png)
Agenzia Italiana del Farmaco
home
Highlights
-
18 Mar 2026
Press releases
AIFA clarification on the opinion regarding reimbursement of Alzheimer's medicines
Once the procedure has been formally completed, the Agency will publicly communicate the outcome.
-
16 Mar 2026
Press releases
AIFA strengthens its commitment to inclusion
The initiative aims to make communication accessibility a structural part of all the Agency's activities, continuously ensuring full participation and equal opportunities for all staff.
-
09 Mar 2026
Technical and advisory committees
The Regulation on the organisation and functioning of the AIFA Scientific and Economic Committee has been published
The Italian Medicines Agency has published the Regulation containing rules on the organisation and functioning of the Scientific and Economic Committee for Medicines
-
26 Feb 2026
Press releases
Duchenne and multiple myeloma: the NHS reimburses two innovative therapies
AIFA Board of Directors Approves 6 new medicines (4 for rare diseases) and new indications in oncology.
News
20 Mar 2026
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Remsima (infliximab)
16 Mar 2026
Transparency Lists
AIFA updates the Transparency Lists
13 Mar 2026
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 March 2026
27 Feb 2026
Press releases
AIFA supports the Rare Disease Day 2026
24 Feb 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 30 September 2025
23 Feb 2026
Medicinal product supply regime
New guidelines on the definition and classification of OTC and SOP medicines
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
